Xenotransplantation, Meaning, Pig Kidney Transplant to Human

Xenotransplantation is the use of living animal cells, tissues, or organs in humans. It is being studied as a response to the shortage of human donor organs. Recent pig kidney research has strengthened its role as a possible bridge for patients with end stage kidney disease. Genetically modified pigs are central to this approach because their organs can be altered to improve compatibility with the human body.

Pig Xenotransplantation Latest News 2026

Research published in The Lancet on September 3, 2026, reported an important development in Pig Kidney Transplantation and its possible use before a human donor organ becomes available.

• Tim Andrews is a US Patient with Kidney Failure. He received a genetically edited pig kidney in 2025 at age 66. In 2026, he received a deceased donor human kidney after remaining dialysis free for 271 days.
• Andrews represents the longest dialysis free survival reported after porcine kidney Xenotransplantation in a living human. His case is also the first documented transition from a pig kidney to a human kidney.
• The genetically edited pig kidney began functioning immediately. An early episode of T cell mediated rejection was controlled with treatment.
• After about six months, immunosuppression was reduced because of infection. The pig kidney later developed microvascular injury and inflammation that progressed to organ failure.
• Andrews subsequently received a deceased donor human kidney. The human kidney showed immediate graft function and follow up found no evidence of sensitization.

What is Xenotransplantation?

The Meaning of Xenotransplantation is transferring living biological material between a non human animal and a human. It includes organs, tissues and cells. It can also cover human material that has had direct contact with living animal cells, tissues or organs outside the body.

• FDA definition: The US Food and Drug Administration defines Xenotransplantation as transplantation, implantation or infusion of live non human animal cells, tissues or organs into humans, including certain human materials exposed to animal biological material ex vivo.
• Purpose: The principal objective is to overcome the shortage of human donor organs. Genetically modified animal organs may provide another source for patients who cannot receive human organs quickly.

‹ ›

What is Transplantation?

Transplantation involves moving an organ, tissue or cells to restore or support function. The source and genetic relationship between donor and recipient determine the major transplantation categories as highlighted below:

• Autotransplantation: Autotransplantation moves tissue from one part of a person’s body to another part of the same body. Skin grafting is a common example.
• Allotransplantation: Allotransplantation occurs between two genetically different people of the same species. Most human organ transplants fall under this category.
• Isograft: An isograft is performed between genetically identical individuals, such as identical twins. Genetic similarity generally reduces immune compatibility problems.
• Xenotransplantation: Xenotransplantation involves biological material from a different species. Pig to human organ transplantation is a major area of current research.

What is the Need for Xenotransplantation?

The shortage of suitable human organs remains a major barrier to transplantation. Xenotransplantation could provide additional organs for patients who otherwise face prolonged waiting periods.

• Kidney shortage: Nearly 90,000 people in the United States are waiting for a kidney transplant. More than 3,000 people die annually while waiting for a kidney.
• Bridge therapy: Xenotransplantation could temporarily support patients with organ failure until a suitable human donor becomes available. This approach could reduce dependence on prolonged dialysis.
• Potential supply: Genetically modified pigs could provide a controlled and scalable source of organs. This may help address the limited availability of human donor organs.

Xenotransplantation in India

India has explored Xenotransplantation since 1997, but growing research and organ shortages highlight the need for clear laws, ethical safeguards and dedicated regulation.

• Liver Requirement in India: India requires around 25,000-30,000 liver transplants annually. Only about 1,500 patients receive them, showing the large gap between demand and available transplantation.
• Organ Shortage: India’s organ donation rate is about 0.86 per million population. Studies estimate that only 2-3 per cent of transplant demand is currently met, creating a strong need for alternative organ sources.
• First Xenotransplantation in India: In January 1997, Dhaniram Baruah performed a pig to human heart transplant in Sonapur, Assam. Patient Purno Saikia died after seven days from acute organ rejection.
• Legal controversy: The 1997 procedure lacked prior approval and ethical oversight. Baruah was arrested under the Transplantation of Human Organs and Tissues Act 1994 and spent 40 days in jail before receiving bail.
• Regulatory position: India has no dedicated Xenotransplantation law. The ICMR 2007 ethical guidelines discussed Xenotransplantation but permitted only animal to animal experimental transplantation, while the 2017 updated guidelines omitted specific references to it.
• Drug-Law Regulation: The New Drugs and Clinical Trials Rules 2019 classify xenografts intended for use as drugs as “New Drugs”. A proposed October 2025 amendment to the Drugs and Cosmetics Rules 1945, sought to bring xenografts within licensing and regulatory provisions.
• Need for Dedicated Framework: Future regulation needs to address human safety, infection surveillance, donor animal selection, informed consent and animal welfare. It should also coordinate the Prevention of Cruelty to Animals Act 1960 and CCSEA requirements with transplantation standards.

Why are Pigs Used for Xenotransplantation?

Pigs are considered suitable animal donors for Xenotransplantation because their organs have important similarities with human organs. Their established farming systems also support controlled production and research.

• Biological similarity: Pig anatomy and physiology have similarities with humans. These characteristics make pig organs suitable candidates for research into human transplantation.
• Established medical use: Pig heart valves have been used in human valve replacement procedures for more than 50 years. This provides considerable experience with porcine biological materials.
• Availability: Pigs are widely farmed and can be bred under controlled conditions. This creates a potentially scalable source of organs compared with limited human donation.
• Organ size: Different pig breeds provide variations in body and organ size. This allows researchers to consider organ dimensions when matching organs with human recipients.

Xenotransplantation History

The development of Xenotransplantation has progressed from early animal experiments to genetically engineered organs. Advances in surgery, immunosuppression, cloning and gene editing have gradually improved its prospects.

• Early experiments: Between the 17th and 20th centuries, animal blood was transfused into humans for different medical conditions. Animal skin graft experiments were also attempted during the 19th century.
• Pig Corneal: In 1838, a pig cornea was used in an early corneal Xenotransplantation attempt. It preceded the development of modern human to human corneal transplantation.
• Chimpanzee kidneys: In 1963-1964, Reemtsma transplanted chimpanzee kidneys into 13 patients. One recipient survived for almost nine months and returned to work before dying suddenly.
• Chimpanzee heart: In 1964, Hardy performed an attempted chimpanzee to human heart transplant. The patient survived for only about two hours.
• Chimpanzee Liver: Starzl performed the first chimpanzee to human liver transplantation in 1966. In 1992, a baboon liver transplant achieved 70 days of patient survival.
• Pig heart: In January 2022, a genetically modified pig heart was transplanted into a 57 year old patient. The patient died about two months later, but the procedure demonstrated the potential of modified pig organs.
• Genetically Modified Pig Kidney: In 2024, Massachusetts General Hospital performed the world’s first genetically engineered pig kidney transplant in a living human. That patient survived 52 days before dying from cardiac causes unrelated to the transplant.
• Pig Liver: In 2025, researchers from the Fourth Military Medical University, Xi’an, transplanted a gene edited pig liver into a brain dead human recipient. The liver produced bile and albumin and maintained stable blood flow for 10 days without observed rejection under immunosuppression.
• Indian case: In 1997, a surgeon in Assam performed a pig heart to human transplant. The patient died one week later and the case resulted in legal repercussions.

Xenotransplantation Procedure and Methodology

The procedure fo Xenotransplantation combines organ selection, genetic modification, transplantation and prolonged monitoring. Pig organs are prepared to reduce rejection and improve their ability to function inside a human recipient.

• Organ selection: Researchers select an animal organ according to its size, function and suitability for the intended recipient. Pig kidneys are among the leading organs under investigation.
• Gene editing: Selected pigs can undergo genetic changes that remove or modify genes responsible for strong human immune reactions. Human genes may also be inserted to improve compatibility.
• CRISPR Cas9: CRISPR Cas9 uses guide RNA to direct the Cas9 enzyme toward a selected DNA sequence. Cas9 cuts the DNA, allowing targeted genetic changes during cellular repair.
• Transplantation: The genetically modified organ is surgically connected to the recipient’s blood vessels and relevant anatomical structures. Doctors then assess immediate blood flow and organ function.
• Immunosuppression: Medicines are used to control the recipient’s immune response. Careful adjustment is required because excessive immunosuppression can increase infection risks.
• Post transplant monitoring: Patients are monitored for rejection, organ performance, antibody formation and potential pig to human pathogen transmission. Long term observation is essential because complications can develop later.

Xenotransplantation Challenges

Xenotransplantation faces major medical, public health and ethical challenges. Long term safety remains uncertain because animal organs interact with the human immune system in complex ways.

• Immune rejection: The human immune system can recognise animal tissues as foreign. Genetic modification and immunosuppressive treatment are therefore required to improve graft survival.
• Zoonotic diseases: Animal to human transplantation may transmit known or unknown pathogens, including viruses that could remain undetected for years. Continuous donor animal screening and long term recipient monitoring are therefore essential.
• Retroviruses: Animal retroviruses may remain latent after transmission. Their ability to cause disease years later creates an important long term public health concern.
• Long term survival: The ability of a pig organ to function for many years inside a human remains uncertain. The 271 day survival of Andrews was an important advance, but it does not establish lifelong durability.
• Ethical concerns: Xenotransplantation raises questions about animal welfare and the permanent genetic modification of animals. These concerns remain important alongside medical considerations.
• Cost and infrastructure: Xenotransplantation requires specialised facilities, genetic engineering, transplantation expertise and long term monitoring. These requirements may limit access in countries with weaker healthcare infrastructure.

Xenotransplantation Significance

Xenotransplantation could change organ transplantation by providing an additional source of organs. Recent pig kidney research shows growing potential, while also highlighting the need for stronger evidence on safety and long term survival.

• Reducing organ shortage: A reliable supply of genetically modified pig organs could reduce dependence on scarce human donors. This could shorten waiting periods for patients with severe organ failure.
• Broader applications: Research is examining animal derived cells, tissues and organs for conditions including diabetes, liver failure and neurodegenerative disorders. Human biological material is often limited for these applications.
• Scientific advancement: Xenotransplantation combines transplantation medicine with genetic engineering and infection surveillance. Its development is also improving understanding of rejection, graft injury and organ compatibility.
• Future potential: The long term objective is a dependable supply of suitable organs from carefully controlled genetically modified pigs. Current evidence supports continued research, but widespread clinical use still requires stronger safety and durability data.